Join
Live feed
·
PRReleasevia Quantisnow
Catalyst Pharmaceuticals Inc. logo

Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

ByQuantisnow·Wall Street's wire, on your screen.
CPRX· Catalyst Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPRX (Catalyst Pharmaceuticals Inc.) and more on Quantisnow.